M3, Inc.
M3, Inc. MTHRY Peers
See (MTHRY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MTHRY | $6.67 | -0.30% | 9.1B | 31.90 | $0.21 | N/A |
| PMCUF | $185.40 | +0.22% | 19.4B | 303.93 | $0.61 | +0.16% |
| MTHRF | $13.65 | +0.00% | 9.3B | 33.29 | $0.41 | +1.03% |
| PANHF | $0.91 | +0.00% | 2B | 90.90 | $0.01 | +137.13% |
| PIAHY | $2.29 | +0.00% | 1.2B | 114.50 | $0.02 | +108.54% |
| CMPVF | $23.75 | -0.44% | 1.2B | 40.95 | $0.58 | +4.21% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| RSLBF | $32.05 | +0.00% | 1.1B | 47.84 | $0.67 | +0.98% |
| CRWRF | $29.25 | +0.00% | 1B | 69.64 | $0.42 | +1.29% |
| SUSRF | $15.10 | +0.00% | 770.5M | 52.07 | $0.29 | N/A |
Stock Comparison
MTHRY vs PMCUF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PMCUF has a market cap of 19.4B. Regarding current trading prices, MTHRY is priced at $6.67, while PMCUF trades at $185.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PMCUF's P/E ratio is 303.93. In terms of profitability, MTHRY's ROE is +0.09%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, MTHRY is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MTHRF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MTHRF has a market cap of 9.3B. Regarding current trading prices, MTHRY is priced at $6.67, while MTHRF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MTHRF's P/E ratio is 33.29. In terms of profitability, MTHRY's ROE is +0.09%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, MTHRY is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PANHF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PANHF has a market cap of 2B. Regarding current trading prices, MTHRY is priced at $6.67, while PANHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PANHF's P/E ratio is 90.90. In terms of profitability, MTHRY's ROE is +0.09%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, MTHRY is more volatile compared to PANHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PIAHY Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PIAHY has a market cap of 1.2B. Regarding current trading prices, MTHRY is priced at $6.67, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PIAHY's P/E ratio is 114.50. In terms of profitability, MTHRY's ROE is +0.09%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, MTHRY is more volatile compared to PIAHY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CMPVF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CMPVF has a market cap of 1.2B. Regarding current trading prices, MTHRY is priced at $6.67, while CMPVF trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CMPVF's P/E ratio is 40.95. In terms of profitability, MTHRY's ROE is +0.09%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, MTHRY is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CMPUY Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, MTHRY is priced at $6.67, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, MTHRY's ROE is +0.09%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, MTHRY is more volatile compared to CMPUY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs RSLBF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, RSLBF has a market cap of 1.1B. Regarding current trading prices, MTHRY is priced at $6.67, while RSLBF trades at $32.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas RSLBF's P/E ratio is 47.84. In terms of profitability, MTHRY's ROE is +0.09%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, MTHRY is more volatile compared to RSLBF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CRWRF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CRWRF has a market cap of 1B. Regarding current trading prices, MTHRY is priced at $6.67, while CRWRF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CRWRF's P/E ratio is 69.64. In terms of profitability, MTHRY's ROE is +0.09%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, MTHRY is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SUSRF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SUSRF has a market cap of 770.5M. Regarding current trading prices, MTHRY is priced at $6.67, while SUSRF trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SUSRF's P/E ratio is 52.07. In terms of profitability, MTHRY's ROE is +0.09%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, MTHRY is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SMSZF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SMSZF has a market cap of 727.3M. Regarding current trading prices, MTHRY is priced at $6.67, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SMSZF's P/E ratio is 17.47. In terms of profitability, MTHRY's ROE is +0.09%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, MTHRY is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs VHIBF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, VHIBF has a market cap of 433.8M. Regarding current trading prices, MTHRY is priced at $6.67, while VHIBF trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas VHIBF's P/E ratio is 267.83. In terms of profitability, MTHRY's ROE is +0.09%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, MTHRY is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs KSIOF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, KSIOF has a market cap of 412.9M. Regarding current trading prices, MTHRY is priced at $6.67, while KSIOF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas KSIOF's P/E ratio is -218.70. In terms of profitability, MTHRY's ROE is +0.09%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, MTHRY is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SMDCF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, MTHRY is priced at $6.67, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, MTHRY's ROE is +0.09%, compared to SMDCF's ROE of N/A. Regarding short-term risk, MTHRY is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs DLHTF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, MTHRY is priced at $6.67, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, MTHRY's ROE is +0.09%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, MTHRY is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs COGZF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, COGZF has a market cap of 202.7M. Regarding current trading prices, MTHRY is priced at $6.67, while COGZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas COGZF's P/E ratio is 30.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, MTHRY is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs VPAHF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, MTHRY is priced at $6.67, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, MTHRY is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ACMLF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ACMLF has a market cap of 150.9M. Regarding current trading prices, MTHRY is priced at $6.67, while ACMLF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ACMLF's P/E ratio is 35.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, MTHRY is more volatile compared to ACMLF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ONVVF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ONVVF has a market cap of 133.1M. Regarding current trading prices, MTHRY is priced at $6.67, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, MTHRY is more volatile compared to ONVVF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CSAMF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, MTHRY is priced at $6.67, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, MTHRY's ROE is +0.09%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, MTHRY is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MDPEF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MDPEF has a market cap of 61.3M. Regarding current trading prices, MTHRY is priced at $6.67, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MDPEF's P/E ratio is 6.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to MDPEF's ROE of N/A. Regarding short-term risk, MTHRY is more volatile compared to MDPEF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HITC Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, MTHRY is priced at $6.67, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HITC's P/E ratio is -14.75. In terms of profitability, MTHRY's ROE is +0.09%, compared to HITC's ROE of -1.29%. Regarding short-term risk, MTHRY is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs RQHTF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, RQHTF has a market cap of 30.4M. Regarding current trading prices, MTHRY is priced at $6.67, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, MTHRY's ROE is +0.09%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, MTHRY is more volatile compared to RQHTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs RTNXF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, MTHRY is priced at $6.67, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, MTHRY's ROE is +0.09%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, MTHRY is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs TREIF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, TREIF has a market cap of 22.1M. Regarding current trading prices, MTHRY is priced at $6.67, while TREIF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas TREIF's P/E ratio is -2.09. In terms of profitability, MTHRY's ROE is +0.09%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, MTHRY is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs VASO Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, VASO has a market cap of 22M. Regarding current trading prices, MTHRY is priced at $6.67, while VASO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas VASO's P/E ratio is 12.51. In terms of profitability, MTHRY's ROE is +0.09%, compared to VASO's ROE of +0.04%. Regarding short-term risk, MTHRY is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HDSLF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, MTHRY is priced at $6.67, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, MTHRY's ROE is +0.09%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, MTHRY is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs THKKF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, MTHRY is priced at $6.67, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas THKKF's P/E ratio is -1.51. In terms of profitability, MTHRY's ROE is +0.09%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, MTHRY is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs DGNOF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, DGNOF has a market cap of 15.7M. Regarding current trading prices, MTHRY is priced at $6.67, while DGNOF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas DGNOF's P/E ratio is -3.85. In terms of profitability, MTHRY's ROE is +0.09%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, MTHRY is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MDBIF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MDBIF has a market cap of 15.1M. Regarding current trading prices, MTHRY is priced at $6.67, while MDBIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MDBIF's P/E ratio is -2.43. In terms of profitability, MTHRY's ROE is +0.09%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, MTHRY is more volatile compared to MDBIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MNNDF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, MTHRY is priced at $6.67, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, MTHRY's ROE is +0.09%, compared to MNNDF's ROE of N/A. Regarding short-term risk, MTHRY is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PBSV Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PBSV has a market cap of 13.8M. Regarding current trading prices, MTHRY is priced at $6.67, while PBSV trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PBSV's P/E ratio is -60.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, MTHRY is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CRVW Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CRVW has a market cap of 11.7M. Regarding current trading prices, MTHRY is priced at $6.67, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CRVW's P/E ratio is -2.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, MTHRY is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs UDOCF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, UDOCF has a market cap of 10.7M. Regarding current trading prices, MTHRY is priced at $6.67, while UDOCF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas UDOCF's P/E ratio is -2.33. In terms of profitability, MTHRY's ROE is +0.09%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, MTHRY is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CDXFF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, MTHRY is priced at $6.67, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, MTHRY's ROE is +0.09%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, MTHRY is more volatile compared to CDXFF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HSCHF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HSCHF has a market cap of 9.5M. Regarding current trading prices, MTHRY is priced at $6.67, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HSCHF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs VYND Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, VYND has a market cap of 9.2M. Regarding current trading prices, MTHRY is priced at $6.67, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas VYND's P/E ratio is -49.99. In terms of profitability, MTHRY's ROE is +0.09%, compared to VYND's ROE of +0.48%. Regarding short-term risk, MTHRY is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HBCNF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, MTHRY is priced at $6.67, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, MTHRY's ROE is +0.09%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, MTHRY is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SPLTF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, MTHRY is priced at $6.67, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, MTHRY's ROE is +0.09%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, MTHRY is more volatile compared to SPLTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs AIMLF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, AIMLF has a market cap of 7.5M. Regarding current trading prices, MTHRY is priced at $6.67, while AIMLF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas AIMLF's P/E ratio is -1.07. In terms of profitability, MTHRY's ROE is +0.09%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, MTHRY is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CRBKF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, MTHRY is priced at $6.67, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, MTHRY's ROE is +0.09%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, MTHRY is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EMOR Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EMOR has a market cap of 6.6M. Regarding current trading prices, MTHRY is priced at $6.67, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EMOR's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, MTHRY is more volatile compared to EMOR. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs DOCRF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, MTHRY is priced at $6.67, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, MTHRY's ROE is +0.09%, compared to DOCRF's ROE of -2.21%. Regarding short-term risk, MTHRY is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CNONF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CNONF has a market cap of 5M. Regarding current trading prices, MTHRY is priced at $6.67, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CNONF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, MTHRY is more volatile compared to CNONF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs RYAHF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, RYAHF has a market cap of 5M. Regarding current trading prices, MTHRY is priced at $6.67, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, MTHRY's ROE is +0.09%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs IQAIF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, MTHRY is priced at $6.67, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas IQAIF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, MTHRY is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CMPD Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CMPD has a market cap of 4.4M. Regarding current trading prices, MTHRY is priced at $6.67, while CMPD trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CMPD's P/E ratio is -15.30. In terms of profitability, MTHRY's ROE is +0.09%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, MTHRY is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs LVCE Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, LVCE has a market cap of 4.3M. Regarding current trading prices, MTHRY is priced at $6.67, while LVCE trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas LVCE's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to LVCE's ROE of N/A. Regarding short-term risk, MTHRY is more volatile compared to LVCE. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CBDS Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, MTHRY is priced at $6.67, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CBDS's P/E ratio is -1.48. In terms of profitability, MTHRY's ROE is +0.09%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, MTHRY is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CTVEF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CTVEF has a market cap of 3.9M. Regarding current trading prices, MTHRY is priced at $6.67, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, MTHRY's ROE is +0.09%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, MTHRY is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EKGGF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EKGGF has a market cap of 3.3M. Regarding current trading prices, MTHRY is priced at $6.67, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EKGGF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, MTHRY is more volatile compared to EKGGF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MITI Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MITI has a market cap of 3.2M. Regarding current trading prices, MTHRY is priced at $6.67, while MITI trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MITI's P/E ratio is -9.33. In terms of profitability, MTHRY's ROE is +0.09%, compared to MITI's ROE of -0.05%. Regarding short-term risk, MTHRY is more volatile compared to MITI. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CMHSF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CMHSF has a market cap of 2.2M. Regarding current trading prices, MTHRY is priced at $6.67, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CMHSF's P/E ratio is 1.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, MTHRY is more volatile compared to CMHSF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EBYH Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EBYH has a market cap of 2.1M. Regarding current trading prices, MTHRY is priced at $6.67, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EBYH's P/E ratio is -6.10. In terms of profitability, MTHRY's ROE is +0.09%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, MTHRY is more volatile compared to EBYH. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs BNVIF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, BNVIF has a market cap of 1.7M. Regarding current trading prices, MTHRY is priced at $6.67, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas BNVIF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, MTHRY is more volatile compared to BNVIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MDXL Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MDXL has a market cap of 801K. Regarding current trading prices, MTHRY is priced at $6.67, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MDXL's P/E ratio is -0.10. In terms of profitability, MTHRY's ROE is +0.09%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, MTHRY is more volatile compared to MDXL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs DTRK Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, DTRK has a market cap of 680.8K. Regarding current trading prices, MTHRY is priced at $6.67, while DTRK trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas DTRK's P/E ratio is -4.84. In terms of profitability, MTHRY's ROE is +0.09%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, MTHRY is more volatile compared to DTRK. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs NEWUF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, NEWUF has a market cap of 634.6K. Regarding current trading prices, MTHRY is priced at $6.67, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas NEWUF's P/E ratio is -0.03. In terms of profitability, MTHRY's ROE is +0.09%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, MTHRY is more volatile compared to NEWUF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EVAHF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EVAHF has a market cap of 557.6K. Regarding current trading prices, MTHRY is priced at $6.67, while EVAHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EVAHF's P/E ratio is -4.80. In terms of profitability, MTHRY's ROE is +0.09%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, MTHRY is less volatile compared to EVAHF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MDRM Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MDRM has a market cap of 535.7K. Regarding current trading prices, MTHRY is priced at $6.67, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MDRM's P/E ratio is -0.42. In terms of profitability, MTHRY's ROE is +0.09%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, MTHRY is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MDNWF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, MTHRY is priced at $6.67, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, MTHRY's ROE is +0.09%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, MTHRY is more volatile compared to MDNWF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CSOC Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CSOC has a market cap of 498.1K. Regarding current trading prices, MTHRY is priced at $6.67, while CSOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CSOC's P/E ratio is 0.18. In terms of profitability, MTHRY's ROE is +0.09%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, MTHRY is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs TSTTF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, TSTTF has a market cap of 461.3K. Regarding current trading prices, MTHRY is priced at $6.67, while TSTTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas TSTTF's P/E ratio is -1.67. In terms of profitability, MTHRY's ROE is +0.09%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, MTHRY is more volatile compared to TSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs NDATF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, NDATF has a market cap of 450.5K. Regarding current trading prices, MTHRY is priced at $6.67, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas NDATF's P/E ratio is -0.55. In terms of profitability, MTHRY's ROE is +0.09%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, MTHRY is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ACHKF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, MTHRY is priced at $6.67, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, MTHRY's ROE is +0.09%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, MTHRY is more volatile compared to ACHKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs NHIQ Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, NHIQ has a market cap of 302.2K. Regarding current trading prices, MTHRY is priced at $6.67, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas NHIQ's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, MTHRY is more volatile compared to NHIQ. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs LFCOF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, LFCOF has a market cap of 282K. Regarding current trading prices, MTHRY is priced at $6.67, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, MTHRY's ROE is +0.09%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, MTHRY is more volatile compared to LFCOF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ALDNF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, MTHRY is priced at $6.67, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ALDNF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs USPS Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, USPS has a market cap of 158.5K. Regarding current trading prices, MTHRY is priced at $6.67, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas USPS's P/E ratio is -1.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to USPS's ROE of -0.63%. Regarding short-term risk, MTHRY is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EMYSF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EMYSF has a market cap of 151.7K. Regarding current trading prices, MTHRY is priced at $6.67, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EMYSF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to EMYSF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs DSOL Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, MTHRY is priced at $6.67, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas DSOL's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, MTHRY is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ICCO Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ICCO has a market cap of 71.7K. Regarding current trading prices, MTHRY is priced at $6.67, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ICCO's P/E ratio is -0.40. In terms of profitability, MTHRY's ROE is +0.09%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, MTHRY is more volatile compared to ICCO. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs REFG Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, MTHRY is priced at $6.67, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas REFG's P/E ratio is -0.01. In terms of profitability, MTHRY's ROE is +0.09%, compared to REFG's ROE of +0.01%. Regarding short-term risk, MTHRY is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HDVY Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, MTHRY is priced at $6.67, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HDVY's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs IGRW Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, MTHRY is priced at $6.67, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas IGRW's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, MTHRY is more volatile compared to IGRW. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs RVRC Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, RVRC has a market cap of 39.2K. Regarding current trading prices, MTHRY is priced at $6.67, while RVRC trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas RVRC's P/E ratio is -0.11. In terms of profitability, MTHRY's ROE is +0.09%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, MTHRY is more volatile compared to RVRC. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs WMGR Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, MTHRY is priced at $6.67, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas WMGR's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, MTHRY is less volatile compared to WMGR. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SSYNF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, MTHRY is priced at $6.67, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to SSYNF's ROE of N/A. Regarding short-term risk, MTHRY is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs SOFE Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, SOFE has a market cap of 31K. Regarding current trading prices, MTHRY is priced at $6.67, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas SOFE's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, MTHRY is more volatile compared to SOFE. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs TTBLF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, MTHRY is priced at $6.67, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, MTHRY is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ORHB Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ORHB has a market cap of 25.6K. Regarding current trading prices, MTHRY is priced at $6.67, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ORHB's P/E ratio is -0.01. In terms of profitability, MTHRY's ROE is +0.09%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, MTHRY is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs EWLL Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, MTHRY is priced at $6.67, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas EWLL's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to EWLL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs NHEL Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, MTHRY is priced at $6.67, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas NHEL's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs FDBH Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, MTHRY is priced at $6.67, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas FDBH's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, MTHRY is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs HLTT Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, MTHRY is priced at $6.67, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas HLTT's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, MTHRY is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PPJE Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PPJE has a market cap of 9.2K. Regarding current trading prices, MTHRY is priced at $6.67, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PPJE's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, MTHRY is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs CGNSF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, MTHRY is priced at $6.67, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas CGNSF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, MTHRY is more volatile compared to CGNSF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs MOSTQ Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, MTHRY is priced at $6.67, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, MTHRY's ROE is +0.09%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, MTHRY is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ACNV Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, MTHRY is priced at $6.67, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ACNV's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to ACNV. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs AHGIF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, MTHRY is priced at $6.67, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas AHGIF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, MTHRY is more volatile compared to AHGIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs NMXS Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, NMXS has a market cap of 3.8K. Regarding current trading prices, MTHRY is priced at $6.67, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas NMXS's P/E ratio is -0.01. In terms of profitability, MTHRY's ROE is +0.09%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, MTHRY is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs BBLNF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, MTHRY is priced at $6.67, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas BBLNF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, MTHRY is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PCYS Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, MTHRY is priced at $6.67, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PCYS's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, MTHRY is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs OLMM Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, MTHRY is priced at $6.67, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas OLMM's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to OLMM. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs PASO Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, PASO has a market cap of 741. Regarding current trading prices, MTHRY is priced at $6.67, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas PASO's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to PASO's ROE of +6.20%. Regarding short-term risk, MTHRY is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs ETAOF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, MTHRY is priced at $6.67, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas ETAOF's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, MTHRY is more volatile compared to ETAOF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs LGBI Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, LGBI has a market cap of 50. Regarding current trading prices, MTHRY is priced at $6.67, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas LGBI's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, MTHRY is more volatile compared to LGBI. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs APYI Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, APYI has a market cap of 34. Regarding current trading prices, MTHRY is priced at $6.67, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas APYI's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to APYI's ROE of -0.60%. Regarding short-term risk, MTHRY is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs VMCS Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, VMCS has a market cap of 0. Regarding current trading prices, MTHRY is priced at $6.67, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas VMCS's P/E ratio is N/A. In terms of profitability, MTHRY's ROE is +0.09%, compared to VMCS's ROE of +3.10%. Regarding short-term risk, MTHRY is less volatile compared to VMCS. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRY.
MTHRY vs WTEQF Comparison
MTHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRY stands at 9.1B. In comparison, WTEQF has a market cap of 0. Regarding current trading prices, MTHRY is priced at $6.67, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRY currently has a P/E ratio of 31.90, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, MTHRY's ROE is +0.09%, compared to WTEQF's ROE of N/A. Regarding short-term risk, MTHRY is more volatile compared to WTEQF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRY.